Healthcare | June 29, 2023
GenWorks Health launches IVD tests for dengue and malaria
Rapid card test kits for iScreen malaria card antigen (Pf/Pv) & iScreen dengue NS1
Rapid card test kits for iScreen malaria card antigen (Pf/Pv) & iScreen dengue NS1
The booster vaccine can be administered safely to individuals who have received two doses of either Covaxin or Covishield
Columvi is part of Roche's industry-leading portfolio of T-cell engaging bispecific antibodies in non-Hodgkin lymphoma, which also includes the recently approved Lunsumio to treat follicular lymphoma
One thousand times more soluble than L-cystine at neutral pH
Acquisition enhances Freenome's product portfolio, including autoantibody platform with additional biomarkers important in cancer detection
This approval reflects Biocon Biologics' compliance with the highest international regulatory standards
New high-tech facility in Biberach offers attractive workplaces for more than 500 scientists
The milestone of operating continuously a very complex system for over two years has demonstrated the effectiveness of integrated laboratory automation solutions
Lonza supports development and manufacturing of ABL Bio’s bispecific antibody candidate with a complete and integrated end-to-end solution
Pfizer’s total cumulative revenue from Seagen therapies is expected to reach $36 billion by 2028, according to GlobalData, a leading data and analytics company.
Subscribe To Our Newsletter & Stay Updated
